Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

Bin Zhao1, Li Li, Qing Lu

  • 1Department of Pharmacology, University of California at San Diego, La Jolla, California 92093, USA.

Genes & Development
|January 6, 2011
PubMed

Insights

Angiomotin (AMOT) proteins regulate the Hippo pathway by inhibiting YAP and TAZ, crucial for organ size. AMOT knockdown activates YAP/TAZ, disrupting cell contact inhibition, suggesting a tumor-suppressive role.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The Yes-associated protein (YAP) is a key regulator of organ size, promoting cell proliferation and inhibiting apoptosis.
  • The Hippo tumor suppressor pathway inhibits YAP activity through phosphorylation, leading to cytoplasmic retention and degradation.
  • Angiomotin (AMOT) family proteins are involved in various cellular processes, including cell adhesion and polarity.

Purpose of the Study:

  • To investigate a novel mechanism of YAP regulation by AMOT family proteins.
  • To elucidate the role of AMOT in the Hippo pathway and its connection to cell contact inhibition.
  • To determine if AMOT proteins possess tumor-suppressive functions.

Main Methods:

  • Knockdown of AMOT family protein AMOTL2 in Madin-Darby canine kidney (MDCK) cells.
  • Assessment of YAP localization, phosphorylation, and target gene expression.
  • Evaluation of cell contact inhibition in AMOTL2 knockdown cells, analyzing YAP and TAZ dependency.

Main Results:

  • AMOTL2 knockdown in MDCK cells led to YAP activation, characterized by decreased tight junction localization, reduced phosphorylation, nuclear accumulation, and induced target gene expression.
  • The YAP paralog, TAZ, was similarly regulated by AMOT.
  • AMOTL2 knockdown resulted in a loss of cell contact inhibition, dependent on YAP and TAZ functions.

Conclusions:

  • AMOT family proteins inhibit YAP and TAZ through AMOT-mediated tight junction localization, representing a novel regulatory mechanism within the Hippo pathway.
  • AMOT proteins may function as tumor suppressors by maintaining cell contact inhibition.
  • This study establishes a link between the Hippo pathway and cell contact inhibition via AMOT proteins.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...